Healthcare DIVE January 10, 2025
Rebecca Pifer

Despite a $265 million net loss, investors saw reason for optimism, including renegotiated pharmacy contracts and the close of 70 underperforming stores, in the quarter.

Dive Brief:

  • Walgreens’ first quarter earnings were notably better than Wall Street feared, though the retail pharmacy operator continues to suffer heavy losses as it works to right the ship.
  • On Friday, Walgreens posted financial results that beat analyst expectations with revenue of $39.5 billion, up 7.5% year over year. Still, Walgreens reported a net loss of $265 million, larger than its $67 million loss same time last year, mainly due to costs stemming from ongoing store closures and asset sales.
  • Walgreens’ market value has plummeting in recent years, leading the company to explore...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
ASHP to CMS: 'Change course' on drug pricing
Many independent pharmacists will not stock drugs in the price negotiation program
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year

Share This Article